CLASS II Device recall · Reported 19 Aug 2020 · FDA Enforcement Report

Philips HeartStart MRx, Monitor/Defibrillators recalled

Philips North America is recalling Philips HeartStart MRx, Monitor/Defibrillators. The recall was initiated on 16 Jul 2020 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesAll devices are affected
Quantity recalled95,212 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2794-2020
FDA event ID
85743
Recalling firm
Philips North America, Andover, MA
Classification
Class II
Status
Terminated
Recall initiated
16 Jul 2020
FDA classified
13 Aug 2020
Reported
19 Aug 2020
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Device Malfunction

Timeline

16 Jul 2020Recall initiated by company
13 Aug 2020Classified by FDA+28 days
19 Aug 2020Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

The therapy switch may fail, resulting in the device exhibiting the following behaviors: the device may not perform the selected function, the therapy knob may not change to the energy setting selected, or the device may deliver a shock with an energy level different from the setting selected by the user. These device behaviors could result in a delay in therapy or a failure to deliver the intended therapy.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

Philips HeartStart MRx, Monitor/Defibrillators with model numbers M3535A, M3536A, M3536M, M3536MC, M3536M2, M3536M3, M3536M4, M3536M5, M3536M6, M3536M7, M3536M8, M3536M9 - Product Usage: is intended for use in hospital and pre-hospital settings by qualified medical personnel trained in the operation of the device and qualified by training in basic life support, advanced cardiac life support or defibrillation.

Where it was distributed

Worldwide distribution.

Questions about this recall

Why was it recalled?

The therapy switch may fail, resulting in the device exhibiting the following behaviors: the device may not perform the selected function, the therapy knob may not change to the energy setting selected, or the device may deliver a shock with an energy level different from the setting selected by the user. These device behaviors could result in a delay in therapy or a failure to deliver the intended therapy.

Which lots are affected?

All devices are affected

Where was it sold?

Worldwide distribution.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Philips North America

All 531

Other Pacemakers & Defibrillators recalls

All 494